The Methodological Issues of Using Cross-Sectional Data for Pharmaceutical Health Outcome Analysis

Sharyn Lymer, Laurie Brown

    Research output: Working paperDiscussion paper

    Abstract

    This paper looks at the use of cross-sectional data in pharmaceutical health outcomes
    research. NATSEM attempted cutting edge research on health outcomes using the
    NATSEM-Medicines Australia MedSim basefile. The results from this analysis are
    not robust and are generally quite problematic. The key limitation is that in using
    cross-sectional data it was not able to show that the groups being compared were the
    same except for the use of medications. For future work, it may be preferable to
    explore health outcomes using longitudinal patient level data (for the Australian
    population).
    Original languageEnglish
    Place of PublicationCanberra
    PublisherNATSEM
    Pages1-42
    Number of pages42
    Volume31
    ISBN (Print)1740882512
    Publication statusPublished - 2006

    Fingerprint

    Health
    Pharmaceutical Preparations
    Medicine
    Research

    Cite this

    @techreport{18c548627257466da13529d71aec66a2,
    title = "The Methodological Issues of Using Cross-Sectional Data for Pharmaceutical Health Outcome Analysis",
    abstract = "This paper looks at the use of cross-sectional data in pharmaceutical health outcomesresearch. NATSEM attempted cutting edge research on health outcomes using theNATSEM-Medicines Australia MedSim basefile. The results from this analysis arenot robust and are generally quite problematic. The key limitation is that in usingcross-sectional data it was not able to show that the groups being compared were thesame except for the use of medications. For future work, it may be preferable toexplore health outcomes using longitudinal patient level data (for the Australianpopulation).",
    author = "Sharyn Lymer and Laurie Brown",
    year = "2006",
    language = "English",
    isbn = "1740882512",
    volume = "31",
    pages = "1--42",
    publisher = "NATSEM",
    type = "WorkingPaper",
    institution = "NATSEM",

    }

    The Methodological Issues of Using Cross-Sectional Data for Pharmaceutical Health Outcome Analysis. / Lymer, Sharyn; Brown, Laurie.

    Canberra : NATSEM, 2006. p. 1-42.

    Research output: Working paperDiscussion paper

    TY - UNPB

    T1 - The Methodological Issues of Using Cross-Sectional Data for Pharmaceutical Health Outcome Analysis

    AU - Lymer, Sharyn

    AU - Brown, Laurie

    PY - 2006

    Y1 - 2006

    N2 - This paper looks at the use of cross-sectional data in pharmaceutical health outcomesresearch. NATSEM attempted cutting edge research on health outcomes using theNATSEM-Medicines Australia MedSim basefile. The results from this analysis arenot robust and are generally quite problematic. The key limitation is that in usingcross-sectional data it was not able to show that the groups being compared were thesame except for the use of medications. For future work, it may be preferable toexplore health outcomes using longitudinal patient level data (for the Australianpopulation).

    AB - This paper looks at the use of cross-sectional data in pharmaceutical health outcomesresearch. NATSEM attempted cutting edge research on health outcomes using theNATSEM-Medicines Australia MedSim basefile. The results from this analysis arenot robust and are generally quite problematic. The key limitation is that in usingcross-sectional data it was not able to show that the groups being compared were thesame except for the use of medications. For future work, it may be preferable toexplore health outcomes using longitudinal patient level data (for the Australianpopulation).

    M3 - Discussion paper

    SN - 1740882512

    VL - 31

    SP - 1

    EP - 42

    BT - The Methodological Issues of Using Cross-Sectional Data for Pharmaceutical Health Outcome Analysis

    PB - NATSEM

    CY - Canberra

    ER -